Cephalon will buy Switzerland's Mepha for about $590 million

02/2/2010 | Philadelphia Inquirer, The

Cephalon agreed to pay about $590 million to acquire Swiss drugmaker Mepha, allowing it to double its international business and expand into Europe and two other markets. The acquisition is expected to conclude in 10 to 12 weeks and could enable the biotech firm to tap into branded generics and two other types of pharmaceutical markets.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA